TPF Induction Chemotherapy Increases PD-L1 Expression in Tumour Cells and Immune Cells in Head and Neck Squamous Cell Carcinoma

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2017-000257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Intratumor Heterogeneity of PD-L1 Expression in Head and Neck Squamous Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2019English

PD-L1 Expressing Circulating Tumour Cells in Head and Neck Cancers

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

PD-L1 Is Preferentially Expressed on CD44+ Tumor-Initiating Cells in Head and Neck Squamous Cell Carcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

PD‑L1 Promotes Head and Neck Squamous Cell Carcinoma Cell Growth Through mTOR Signaling

Oncology Reports
MedicineCancer ResearchOncology
2019English

PD-L1-specific Helper T-Cells Exhibit Effective Antitumor Responses: New Strategy of Cancer Immunotherapy Targeting PD-L1 in Head and Neck Squamous Cell Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma

Methods in Molecular Biology
GeneticsMolecular Biology
2009English

Tumor-Associated B Cells and Humoral Immune Response in Head and Neck Squamous Cell Carcinoma

OncoImmunology
OncologyAllergyImmunology
2019English

PD-L1 Expression Predicts Longer Disease Free Survival in High Risk Head and Neck Cutaneous Squamous Cell Carcinoma

Pathology
Forensic MedicinePathology
2017English

Expression of a Novel mRNA in Human Head and Neck Squamous Cell Carcinoma Cells.

Molecular Pathology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy